Latest Cytori Stories
Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
Cytori (NASDAQ: CYTX) received its first order from Green Hospital Supply for a StemSource(R) Cell Bank, which will be installed in one of the leading public universities in Japan.
Two surgeons today reported their experience in performing cell-enhanced reconstruction on 52 patients from Europe and Israel.
Cytori (NASDAQ: CYTX) will host its second quarter results conference call at 10:30 am Eastern Daylight Time, not 10:00 am. About Cytori Cytori's (NASDAQ: CYTX) goal is to be the global leader in regenerative medicine.
Cytori (NASDAQ:CYTX) sold its first European Union StemSource(R) Cell Bank as part of an agreement with Biohellenika (www.biohellenika.gr).
- To give a box on the ear to.